Oscar Health Stock Forecast, Price & News

6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Oscar Health in the last twelve months. There are currently 1 hold rating and 5 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Oscar Health stock.
View analyst ratings for Oscar Health or view top-rated stocks.

Wall Street analysts have given Oscar Health a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Oscar Health wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Oscar Health is scheduled to release its next quarterly earnings announcement on Thursday, May 13th 2021.
View our earnings forecast for Oscar Health.

Oscar Health will be holding an earnings conference call on Thursday, May 13th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

6 brokerages have issued 1-year price objectives for Oscar Health's shares. Their forecasts range from $29.00 to $44.00. On average, they anticipate Oscar Health's share price to reach $37.83 in the next year. This suggests a possible upside of 58.1% from the stock's current price.
View analysts' price targets for Oscar Health or view top-rated stocks among Wall Street analysts.

Some companies that are related to Oscar Health include The Cooper Companies (COO), UCB (UCBJF), Insulet (PODD), MERCK Kommanditgesellschaft auf Aktien (MRK), Avantor (AVTR), Sino Biopharmaceutical (SBMFF), Fresenius Medical Care AG & Co. KGaA (FME), Eurofins Scientific (ERFSF), Catalent (CTLT), Sonova (SONVY), Bio-Rad Laboratories (BIO), Bio-Rad Laboratories (BIO.B), CureVac (CVAC), Incyte (INCY) and Cardinal Health (CAH).
View all of OSCR's competitors.

(OSCR) raised $1 billion in an initial public offering on Wednesday, March 3rd 2021. The company issued 31,000,000 shares at a price of $32.00-$34.00 per share. Goldman Sachs, Morgan Stanley, Allen & Co., Wells Fargo Securities, BofA Securities and Credit Suisse acted as the underwriters for the IPO and Cowen, Lion Tree, Ramirez & Co. and Siebert Williams Shank were co-managers.

Oscar Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "OSCR."

Oscar Health's lock-up period expires on Monday, August 30th. Oscar Health had issued 37,041,026 shares in its public offering on March 3rd. The total size of the offering was $1,444,600,014 based on an initial share price of $39.00. Shares of the company owned by major shareholders and company insiders will be eligible for trade following the end of the lock-up period.

Shares of OSCR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of OSCR stock can currently be purchased for approximately $23.93.

Oscar Health has a market capitalization of $4.86 billion.

Oscar Health employs 1,839 workers across the globe.

The official website for Oscar Health is www.hioscar.com.

The company can be reached via phone at (844) 392-7589.